SARS-CoV-2 spike mRNA is designed for high expression of Covid-19 spike antigen protein production.
 
Our mRNAs are synthesized through in vitro transcription, incorporating N1MePU modified nucleotides, Cap1 and a poly(A) tail at the 3' end. These enhancements promote greater stability, improved translation efficiency, and higher protein yields.
 
✔️ Optimized for Stability & Efficiency
✔️ Variants Available for Specific Research Needs
✔️ Validated Against Real Vaccines
 
These mRNAs are designed to support vaccine development, immunology research, and virology studies by ensuring highly reproducible and scalable results.
 
For Research Use Only. Not intended for human use or consumption.